Clinical experience of using double bronchodilation therapy in patients with COPD

Author:

Demko I. V.1ORCID,Mamayeva M. G.1ORCID,Gordeyeva N. V.1ORCID,Solov’yeva I. A.1ORCID,Kraposhina A. Yu.1ORCID

Affiliation:

1. Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University; Regional clinical hospital

Abstract

Chronic obstructive pulmonary disease is today one of the socially significant diseases, and its treatment remains a major medical problem.Currently, the main goals of treating patients with COPD are: eliminating symptoms and improving the quality of life, preventing exacerbations and reducing future risks, slowing the progression of the disease and reducing mortality.The article presents a clinical case from the practice of a patient with COPD who received tiotropium bromidi as monotherapy. The patient had significant impaired airway patency during spirometry, a decrease in exercise tolerance. The patient was assigned a new representative of combination preparations with a 24-hour action – Anoro Ellipta® (Vilanterol + Umeklidiniy) 22/55 mcg, with a new drug delivery vehicle. After 6 months of therapy with Anoro Ellipt®, the patient has increased exercise tolerance, improved pulmonary function, as well as quality of life. 

Publisher

Remedium, Ltd.

Subject

General Medicine

Reference9 articles.

1. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO workshop report updated 2018. 80 p. Available at: https://goldcopd.org/wp-content/ uploads/2018/11/GOLD-2019-v1.7-FINAL14Nov2018-WMS.pdf.

2. World Health Organization. Evidenceinformed policy-making. 2016. Available at: http://www.who.int/evidence.

3. Sviderskaya L.N., Simakova V.M., Demko I.V., Hendogina V.T., Kudryavceva A.N., Tret’yak T.V. et al. Comparative assessment of the organization of access control and quality of medical care in the conditions of the regional consultative clinic. Sibirskoe medicinskoe obozrenie = Siberian Medical Review. 2016;(5):53-64. (In Russ.) Available at: https://elibrary.ru/item.asp?id=27487911.

4. Cazzola M., Molimard M. The scientific rationale for combining long-acting β2-agonists and muscarinic antagonists in COPD. Pulm Pharmacol Ther. 2010;23(4):257–267. doi: 10.1016/j.pupt.2010.03.003.

5. Vizel’ A.A., Vizel’ I.YU, Bakunina E.A. Chronic obstructive pulmonary disease modern approaches to therapy. Meditsinskiy sovet = Medical Council. 2016;(15):6-10. doi: 10.21518/2079-701X-2016-15-6-10.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Experience of using double bronchodilation therapy in patients with COPD;Meditsinskiy sovet = Medical Council;2021-01-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3